WallStreetZenWallStreetZen

NASDAQ: XNCR
Xencor Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for XNCR

Based on 2 analysts offering 12 month price targets for Xencor Inc

Min Forecast
$6.00-34.71%
Avg Forecast
$19.50+112.19%
Max Forecast
$33.00+259.09%

Should I buy or sell XNCR stock?

Based on 2 analysts offering ratings for Xencor Inc.

Hold
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 50%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their XNCR stock forecasts and price targets.

XNCR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-08
lockedlocked$00.00+00.00%2025-02-28

1 of 1

Forecast return on equity

Is XNCR forecast to generate an efficient return?

Company
-33.59%
Industry
140.91%
Market
90.47%
XNCR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XNCR forecast to generate an efficient return on assets?

Company
-23.76%
Industry
32.45%
XNCR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XNCR earnings per share forecast

What is XNCR's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$3.08
Avg 2 year Forecast
-$2.61
Avg 3 year Forecast
-$2.88

XNCR revenue forecast

What is XNCR's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$96.4M-24.23%
Avg 2 year Forecast
$91.8M-27.82%
Avg 3 year Forecast
$111.5M-12.33%
XNCR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XNCR revenue growth forecast

How is XNCR forecast to perform vs Biotechnology companies and vs the US market?

Company
-6.32%
Industry
56.38%
Market
9.68%
XNCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XNCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XNCR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XNCR$9.19$19.50+112.19%Hold
KALV$12.96$24.83+91.61%Strong Buy
DAWN$6.67$30.17+352.28%Strong Buy
ABUS$3.53$5.00+41.64%Strong Buy
STOK$11.53$27.00+134.17%Strong Buy
View Top Biotech Stocks

Xencor Stock Forecast FAQ

Is Xencor Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: XNCR) stock is to Hold XNCR stock.

Out of 2 analysts, 1 (50%) are recommending XNCR as a Strong Buy, 0 (0%) are recommending XNCR as a Buy, 0 (0%) are recommending XNCR as a Hold, 0 (0%) are recommending XNCR as a Sell, and 1 (50%) are recommending XNCR as a Strong Sell.

If you're new to stock investing, here's how to buy Xencor stock.

What is XNCR's earnings growth forecast for 2025-2027?

(NASDAQ: XNCR) Xencor's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Xencor's earnings in 2025 is -$207,596,000.On average, 8 Wall Street analysts forecast XNCR's earnings for 2025 to be -$219,476,371, with the lowest XNCR earnings forecast at -$256,926,422, and the highest XNCR earnings forecast at -$179,350,300. On average, 8 Wall Street analysts forecast XNCR's earnings for 2026 to be -$186,019,000, with the lowest XNCR earnings forecast at -$236,286,903, and the highest XNCR earnings forecast at -$60,495,141.

In 2027, XNCR is forecast to generate -$204,971,772 in earnings, with the lowest earnings forecast at -$241,268,856 and the highest earnings forecast at -$149,458,583.

What is XNCR's revenue growth forecast for 2025-2027?

(NASDAQ: XNCR) Xencor's forecast annual revenue growth rate of -6.32% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Xencor's revenue in 2025 is $127,228,000.On average, 6 Wall Street analysts forecast XNCR's revenue for 2025 to be $6,860,576,003, with the lowest XNCR revenue forecast at $6,183,315,108, and the highest XNCR revenue forecast at $7,920,593,213. On average, 6 Wall Street analysts forecast XNCR's revenue for 2026 to be $6,535,681,511, with the lowest XNCR revenue forecast at $5,667,327,141, and the highest XNCR revenue forecast at $8,200,294,276.

In 2027, XNCR is forecast to generate $7,938,385,901 in revenue, with the lowest revenue forecast at $6,296,476,606 and the highest revenue forecast at $10,250,011,991.

What is XNCR's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: XNCR) forecast ROA is -23.76%, which is lower than the forecast US Biotechnology industry average of 32.45%.

What is XNCR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year XNCR price target, the average XNCR price target is $19.50, with the highest XNCR stock price forecast at $33.00 and the lowest XNCR stock price forecast at $6.00.

On average, Wall Street analysts predict that Xencor's share price could reach $19.50 by May 8, 2026. The average Xencor stock price prediction forecasts a potential upside of 112.19% from the current XNCR share price of $9.19.

What is XNCR's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: XNCR) Xencor's current Earnings Per Share (EPS) is -$3.05. On average, analysts forecast that XNCR's EPS will be -$3.08 for 2025, with the lowest EPS forecast at -$3.61, and the highest EPS forecast at -$2.52. On average, analysts forecast that XNCR's EPS will be -$2.61 for 2026, with the lowest EPS forecast at -$3.32, and the highest EPS forecast at -$0.85. In 2027, XNCR's EPS is forecast to hit -$2.88 (min: -$3.39, max: -$2.10).

What is XNCR's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: XNCR) forecast ROE is -33.59%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.